21.02.2021
Clean compressed air in vaccine production
Vaccine – What needs more trust?
„I am pleased that AQUAAIR can also help with the production of vaccines.” – Marco Lodni, Managing Partner
mRNA-1273
The COVID-19 vaccine from Moderna
The American biotechnology company „ModeRNA“ develops medicines based on messenger RNA (mRNA).
In March 2020, Moderna was the first company worldwide to receive approval for a clinical trial of its SARS-CoV-2 vaccine candidate mRNA-1273.
On December 18, 2020, the U.S. Food and Drug Administration (FDA) granted the Moderna COVID-19 vaccine an emergency approval.
Rated priority
Production and distribution of the vaccine
By order of the US Department of Defense, the production and distribution of the Modena COVID-19 vaccine was prioritized:
Every company and institution directly or indirectly involved in the production and distribution of the vaccine is urged to treat the task at hand with high priority and, above all, to keep to the demanding schedule.
In January 2021, AQUAAIR received a prioritized order to supply the production of the Moderna vaccine with clean compressed air as quickly as possible. – The second order followed in February 2021 …
When it really matters
Clean compressed air from AQUAAIR
As an OEM of Dräger compressed air systems, AQUAAIR is a leader in supplying hospitals with truly clean compressed air.
When it really matters: Clean compressed air from AQUAAIR meets your highest demands!
We at AQUAAIR say thank you for the trust placed in us and hope that the vaccine will soon bring our normal life back.
